- Investing Ideas
- Australian Pharmaceuticals & Biotech Profitable Climbers
Australian Pharmaceuticals & Biotech Profitable Climbers
Results
2
0 new
2 companies
Clinuvel Pharmaceuticals
Market Cap: AU$498.5m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$9.93
7D
-2.3%
1Y
-13.9%
Neuren Pharmaceuticals
Market Cap: AU$1.5b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$11.76
7D
-4.8%
1Y
0.7%